Oh come on. "95% efficacy" for either Moderna or Pfizer in the FDA process DOES NOT mean "95% less severe hospitalizations and death in vax'ed individuals." This is a strikingly incorrect "correction."https://twitter.com/Laurie_Garrett/status/1359219118315036673 …
-
Show this thread
-
The efficacy endpoint for these trials has been "any symptomatic disease"—even sniffles, headache, fever. That's what the 95% refers to, not "less severe hospitalization & death" which, in the trials (all the trials) have been reduced by 100%. Transmission, is another thing.
20 replies 81 retweets 900 likesShow this thread -
Replying to @zeynep
*except for the JNJ trial, where the primary endpoint was moderate/severe disease, but had the same secondary outcome of prevention(!) of hospitalization & death
1 reply 0 retweets 0 likes
Replying to @amalec
Yeah, waiting for the EUA but that's not authorized in the US yet. We only have the two mRNA vaccines here atm.
12:53 PM - 9 Feb 2021
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.